Karen P. Robards, Director at AtriCure, Inc. (ATRC), bought 1,000 shares at $7.00 ($7K) on 2012-08-16, disclosed to the SEC on 2012-08-16.
Open-market purchase of $7k ATRC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.96 | 500 | $3K | 49.9% |
| 2 | $7.00 | 500 | $4K | 50.1% |
| Total | $6.98 avg | 1,000 | $7K | 100% |
| Filing → |
| BSTZ | BUY | 2019-06-27 | $5K | — | Filing → |
| MSO | BUY | 2019-04-18 | $10K | — | Filing → |
| MSO | BUY | 2018-02-26 | $25K | — | Filing → |